Previous 10 | Next 10 |
2024-03-28 09:30:13 ET Summary S&P 500 and its replica fund, SPDR S&P 500 ETF Trust, have seen positive performance in Q1 2024, and the potential for the top 10 holdings continues to indicate an upside. However, there are risks to consider when considering investing for re...
2024-03-28 09:05:00 ET Getting to a $1 trillion market cap is a huge achievement for a company, as only the best of the best can join that club. Not only do companies need to generate strong results, but investors also need to be optimistic about their future growth for their valuations to ...
2024-03-28 08:00:00 ET Are stock splits back in style? About two years ago, a number of high-profile corporations made such moves after their shares rose to unwieldy levels. Now, Chipotle , one of the leading fast-casual restaurant chains, is on the verge of conducting a 50-for-1 stock ...
2024-03-27 19:50:00 ET Summary Positive results achieved from phase 2 MOMENTUM study, whereby patients not only achieved significant weight loss over a 48-week period with pemvidutide but also had lean mass preservation. It is said that the GLP-1 market could exceed $100 billion b...
2024-03-27 17:02:39 ET More on Novo Nordisk Shaping The Future Of Obesity Treatment: GLP-1 Agonists At The Forefront Novo Nordisk: My 'Hold' Thesis For 2024 - The Premium Must Be Justified Novo Nordisk, A Very Healthy Pharma Stalwart Amazon reportedly leaning...
2024-03-27 08:26:15 ET More on Altimmune Altimmune: Taking On Toughest Of Rivals In Obesity - I'm Unconvinced By Recent Rally Altimmune's Pemvidutide Lacks Differentiation In Obesity Treatment Thoroughly Derisked, Altimmune Is Now A Great Buy Altimmune Q4 202...
2024-03-27 01:00:24 ET Summary XLV tracks the 64 Health Care stocks in the S&P 500 Index. Its expense ratio is 0.10% and the ETF has over $40 billion in assets under management. With a 12% weighting in the S&P 500 Index, Health Care is already well-represented in most port...
2024-03-26 14:15:37 ET More on Amazon, Eli Lilly, etc. Amazon: Still Cheap Even After Robust Rally Amazon Faces Off Against Temu: Who Will Win? Eli Lilly: The Party Is Not Over Amazon making same-day prescription delivery available in NYC and LA Novo ...
2024-03-26 14:01:03 ET More on Cytokinetics Cytokinetics: CEO Talks Down Buyout Prospects Cytokinetics, Incorporated (CYTK) Q4 2023 Earnings Call Transcript Cytokinetics Steps Up As Prime Target After Aficamten's HCM Triumph (Rating Upgrade) Cytokinetics drif...
2024-03-26 11:43:00 ET More on CRISPR Technology Editas Medicine, Inc. (EDIT) Presents at Barclays 26th Annual Global Healthcare Conference (Transcript) Editas Medicine, Inc. (EDIT) Leerink Partners Global Biopharma Conference (Transcript) Editas Medicine, Inc. (EDIT...
News, Short Squeeze, Breakout and More Instantly...
2024-07-27 07:15:00 ET According to some research, bull markets tend to last an average of 2.6 years. The one we are currently experiencing has been going on for almost two years -- maybe it will soon end, maybe it won't. Equities that can perform well throughout bull runs might be good to ...
2024-07-26 07:45:00 ET Over the last 18 months, the stock market has been incredibly generous to investors. Since January 2023, the S&P 500 has soared 45%, while the tech-heavy Nasdaq Composite has rocketed by 72%. Outside of the technology industry, investors have also foun...
2024-07-25 19:06:06 ET It wasn't so long ago when Novo Nordisk (NYSE: NVO) and Eli Lilly (NYSE: LLY) stocks were flying high thanks to their hotly popular weight loss drugs (Wegovy/Ozempic for Novo Nordisk and Zepbound/Mounjaro for Lilly). In the pharmaceutical industry,...